A petition to the FDA calls for the end of sales of some high-dose opioid pills.

The article uses misleading terms such as "high-grade" and "powerful". What distinguishes these pills from other painkillers is not their quality, as the first would imply, nor the strength of effect of the active ingredient, but rather the amount of that ingredient in one pill.

Withdrawing them might be a good idea.